Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | NSD2 | O96028 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | HBB | P68871 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11421896 | 0.84 | MAPT (0.69) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL28256577 | 0.80 | GSK3B (0.44) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL6366580 | 0.78 | ADORA2A (0.58) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL26804289 | 0.78 | MAPK1 (0.43) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL4474776 | 0.78 | MAPT (0.61) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL4465042 | 0.77 | MAPT (0.89) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL27053437 | 0.77 | MAPK1 (0.44) | MAPK1MAPTNSD2KDM4EALDH1A1 | |
| SCHEMBL576094 | 0.77 | ACHE (0.53) | ALDH1A1L3MBTL1CYP3A4TSHRTDP1 | |
| SCHEMBL4485448 | 0.76 | MAPT (0.64) | MAPK1MAPTNSD2KDM4EL3MBTL1 | |
| SCHEMBL14207786 | 0.76 | MAPT (0.73) | MAPK1MAPTNSD2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7494721-B2 | Light-emitting device, condensed polycyclic compound used therein and method for producing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-02-24 | — | — | US | disclosed |
| US-20060051612-A1 | Light-emitting device, condensed polycyclic compound used therein and method for producing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1589089-A1 | LIGHT-EMITTING DEVICE, CONDENSED POLYCYCLIC COMPOUND USED THEREIN AND METHOD FOR PRODUCING SAME | Nippon Kayaku Kabushiki Kaisha (JP) | 2005-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060051612-A1 | Light-emitting device, condensed polycyclic compound used therein and method for producing same | CYBA, SCO2, NQO1 | MAPK1 2071/4885MAPT 2457/4885NSD2 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.